CannaPharmaRx expands board to five; Branson resigns, Panek and Mindle appointed

CANNAPHARMARX, INC.

Mark Branson resigned from board effective March 23, 2023, not due to any dispute.
Board expanded from three to five seats; Anthony Panek and Adam Mindle appointed August 15, 2023.
Panek is a corporate M&A attorney and venture capital investor with cannabis experience.
Mindle is a transactional attorney with extensive real estate, finance, and M&A experience.
Both Panek and Mindle have applied for Health Canada clearance to serve as directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark Branson

Director

CPMD · CANNAPHARMARX, INC.

Effective: 2023-03-23
Successor: Adam Mindle and Anthony Michael Panek
Filed: August 28, 2023, 7:59 PM ET

On March 23, 2023, Mark Branson informed the Board of Directors (the “Board”) of CannaPharmaRx, Inc. (the “Company”) that he intends to resign as a member of the Board effective immediately.

Appointed

Anthony Michael Panek

Director

CPMD · CANNAPHARMARX, INC.

Effective: 2023-08-15
Filed: August 28, 2023, 7:59 PM ET

On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board

Appointed

Adam Mindle

Director

CPMD · CANNAPHARMARX, INC.

Effective: 2023-08-15
Filed: August 28, 2023, 7:59 PM ET

On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Mark Branson resigned as Director at CANNAPHARMARX, INC..

Action: resigned
Role: Director

Exact text from the filing

On March 23, 2023, Mark Branson informed the Board of Directors (the “Board”) of CannaPharmaRx, Inc. (the “Company”) that he intends to resign as a member of the Board effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Anthony Michael Panek was appointed as Director at CANNAPHARMARX, INC..

Action: appointed
Role: Director

Exact text from the filing

On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Adam Mindle was appointed as Director at CANNAPHARMARX, INC..

Action: appointed
Role: Director

Exact text from the filing

On August 15th, 2023, the remaining members of the Board appointed Messrs. Adam Mindle and Anthony Michael Panek as members of the Board

View on SEC.gov

CANNAPHARMARX, INC. filing history →

Source: SEC EDGAR

accession 0001683168-23-006113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.